Search research articles
Contact Us
Filters
Showing results (1-10 of 201) with videos related to
Page
of 21
Sort By:
The Lancet. Gastroenterology & Hepatology
|
November 20, 2020
Hepatitis C among men who have sex with men: knowing your epidemic
Andri Rauch, Gilles Wandeler
Gut
|
February 16, 2020
Hepatitis D virus: is it all in the family?
Anders Boyd, Gilles Wandeler
HIV Medicine
|
April 25, 2023
Tenofovir alafenamide and weight: What do we still need to know to inform clinical decisions?
Bernard Surial, Gilles Wandeler
The Lancet. HIV
|
February 11, 2023
Need for clear inclusion criteria in reviews of antiretroviral treatments
Alexandra Calmy, Gilles Wandeler, Matthias Egger
AIDS (London, England)
|
November 10, 2011
Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient
Gilles Wandeler, Hansjakob Furrer, Andri Rauch
Current Opinion in HIV and AIDS
|
June 3, 2016
Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population
Gilles Wandeler, Leigh F Johnson, Matthias Egger
Expert Review of Gastroenterology & Hepatology
|
May 9, 2018
The current situation and challenges of screening for and treating hepatitis B in sub-Saharan Africa
Charles Béguelin, Fatou Fall, Moussa Seydi, et al.
Current Epidemiology Reports
|
September 17, 2021
Elimination of Viral Hepatitis in Low and Middle-Income Countries: Epidemiological Research Gaps
Antoine Jaquet, Guy Muula, Didier K Ekouevi, et al.
Swiss Medical Weekly
|
February 7, 2015
Hepatitis C: a changing epidemic
Gilles Wandeler, Jean-François Dufour, Philip Bruggmann, et al.
Open Forum Infectious Diseases
|
December 6, 2018
Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
Laura N Walti, Julia Steinrücken, Andri Rauch, et al.
Page
of 21
Search research articles
Search
Showing results (1-10 of 201) with videos related to
Sort By:
Page
of 21
The Lancet. Gastroenterology & Hepatology
|
November 20, 2020
Hepatitis C among men who have sex with men: knowing your epidemic
Andri Rauch, Gilles Wandeler
Gut
|
February 16, 2020
Hepatitis D virus: is it all in the family?
Anders Boyd, Gilles Wandeler
HIV Medicine
|
April 25, 2023
Tenofovir alafenamide and weight: What do we still need to know to inform clinical decisions?
Bernard Surial, Gilles Wandeler
The Lancet. HIV
|
February 11, 2023
Need for clear inclusion criteria in reviews of antiretroviral treatments
Alexandra Calmy, Gilles Wandeler, Matthias Egger
AIDS (London, England)
|
November 10, 2011
Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient
Gilles Wandeler, Hansjakob Furrer, Andri Rauch
Current Opinion in HIV and AIDS
|
June 3, 2016
Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population
Gilles Wandeler, Leigh F Johnson, Matthias Egger
Expert Review of Gastroenterology & Hepatology
|
May 9, 2018
The current situation and challenges of screening for and treating hepatitis B in sub-Saharan Africa
Charles Béguelin, Fatou Fall, Moussa Seydi, et al.
Current Epidemiology Reports
|
September 17, 2021
Elimination of Viral Hepatitis in Low and Middle-Income Countries: Epidemiological Research Gaps
Antoine Jaquet, Guy Muula, Didier K Ekouevi, et al.
Swiss Medical Weekly
|
February 7, 2015
Hepatitis C: a changing epidemic
Gilles Wandeler, Jean-François Dufour, Philip Bruggmann, et al.
Open Forum Infectious Diseases
|
December 6, 2018
Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
Laura N Walti, Julia Steinrücken, Andri Rauch, et al.
Page
of 21